{"brief_title": "A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs", "brief_summary": "This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.", "detailed_description": "Patients are randomized to receive open-label emtricitabine or ABC in combination with stavudine and efavirenz. Viral load and CD4+ cell counts are compared at Weeks 24 and 48. Patients are followed for 48 weeks.", "condition": ["HIV Infections"], "intervention_type": ["Drug", "Drug", "Drug", "Drug"], "intervention_name": ["Abacavir sulfate", "Efavirenz", "Emtricitabine", "Stavudine"], "criteria": "Inclusion Criteria You may be eligible if you: - Are HIV-positive and generally healthy. - Have a viral load of 5,000 copies/ml or more. - Have CD4 cell counts of 200 cells/mm3 or more. - Are age 18 or older. - Agree to practice sexual abstinence or use effective barrier methods of birth control (such as condoms). Exclusion Criteria You will not be eligible if you: - Have ever taken anti-HIV drugs for 3 days or more. - Have had certain AIDS-related infections. - Have had severe diarrhea within the past 30 days. - Are unable to eat at least 1 meal a day due to nausea, vomiting, or stomach pain. - Are being treated for active tuberculosis (TB). - Are pregnant or breast-feeding. - Use illegal drugs or alcohol that make it difficult for you to take study drugs or keep clinic appointments. - Are taking certain medications, or have certain other conditions or diseases (see the technical summary for more detail).", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "efavirenz", "mesh_term": ["HIV Infections", "Abacavir", "Dideoxynucleosides", "Stavudine", "Efavirenz", "Emtricitabine"], "id": "NCT00002362"}